Proc Natl Acad Sci U S A 1973, 70:480–484.PubMedCentralPubMedCrossRef 14. Rotureau
B: Are new world leishmaniases becoming anthroponoses? Med Hypotheses 2006, 67:1235–1241.PubMedCrossRef 15. WHO: Urbanization: an increasing risk factor for leishmaniasis. WklyEpidemiol Rec 2002, 77:365–370. 16. Polonio T, Efferth T: Leishmaniasis: drug resistance and natural products (review). Int Selonsertib molecular weight J Mol Med 2008, 22:277–286.PubMed 17. Sereno D, Lemesre JL: Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother 1997, 41:972–976.PubMedCentralPubMed 18. Sen R, Chatterjee M: Plant derived therapeutics for the treatment of leishmaniasis. Phytomedicine 2011, 18:1056–1059.PubMedCrossRef 19. Kayser O, Kiderlen AF, Croft SL: Natural products as antiparasitic drugs. Parasitol Res 2003, 90:S55-S62.PubMedCrossRef 20. Sikkema J, De Bont JAM, Poolman B: Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 1995, 59:201–222.PubMedCentralPubMed
21. Fumarola L, Spinelli R, Brandonisio O: In vitro assays for evaluation of drug activity against Leishmania spp. Res Microbiol 2004, 155:224–230.PubMedCrossRef 22. Sereno D, Cordeiro Da Silva A, Mathieu-Daude buy Repotrectinib F, Ouaissi A: Advances and perspectives in leishmania cell based drug-screening procedures. Parasitol Int 2007, 56:3–7.PubMedCrossRef 23. Weniger B, Robledo S, Arango GJ, Deharo E, Aragón R, Muñoz V, Callapa J, Lobstein A, Anton R: Antiprotozoal activities of Colombian plants. J Ethnopharmacol 2001, 78:193–200.PubMedCrossRef 24. Weniger B, Vonthron-Sénécheau C, Kaiser M, Brun R, Anton R: Comparative antiplasmodial, leishmanicidal and antitrypanosomal activities of several biflavonoids. Phytomedicine 2006, 13:176–180.PubMedCrossRef 25. Winter MJ, Ellis LCJ, Hutchinson TH: Formation of micronuclei in erythrocytes of the fathead minnow
(Pimephales promelas ) after acute treatment with mitomycin C or cyclophosphamide. Mutat Res 2007, 629:89–99.PubMedCrossRef Glutathione peroxidase 26. Costa MA, Ishida K, Kaplum V, Koslyk ED, de Mello JC, Ueda-Nakamura T, Dias Filho BP, Nakamura CV: Safety evaluation of proanthocyanidin polymer-rich fraction obtained from stem bark of selleck Stryphnodendron adstringens (BARBATIMAO) for use as a pharmacological agent. Regul Toxicol Pharmacol 2010, 58:330–335.PubMedCrossRef 27. Hayashi M, MacGregor JT, Gatehouse DG, Adler I, Blakey DH, Dertinger SD, Krishna G, Morita T, Russo A, Sutou S: In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring. Environ Mol Mutagen 2000, 35:234–252.PubMedCrossRef 28. Edinger AL, Thompson CB: Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004, 16:663–669.PubMedCrossRef 29.